Obstructive sleep apnoea
A Malhotra, DP White - The lancet, 2002 - thelancet.com
Obstructive sleep apnoea is a disease of increasing importance because of its
neurocognitive and cardiovascular sequelae. Abnormalities in the anatomy of the pharynx …
neurocognitive and cardiovascular sequelae. Abnormalities in the anatomy of the pharynx …
Adult obstructive sleep apnoea
AS Jordan, DG McSharry, A Malhotra - The Lancet, 2014 - thelancet.com
Obstructive sleep apnoea is an increasingly common disorder of repeated upper airway
collapse during sleep, leading to oxygen desaturation and disrupted sleep. Features include …
collapse during sleep, leading to oxygen desaturation and disrupted sleep. Features include …
Obstructive sleep apnoea and cardiovascular disease
M Sánchez-de-la-Torre… - The Lancet …, 2013 - thelancet.com
Obstructive sleep apnoea (OSA) is a common health concern caused by repeated episodes
of collapse of the upper airway during sleep. The events associated with OSA lead to brain …
of collapse of the upper airway during sleep. The events associated with OSA lead to brain …
Pathogenesis of obstructive sleep apnoea/hypopnoea syndrome.
NJ Douglas, O Polo - The Lancet, 1994 - elibrary.ru
Discusses the health hazards of obstructive sleep apnea/hypopnea syndrome (SAHS) in
middle-aged men and women. Effect of sleep on upper airway; Effects of upper airway …
middle-aged men and women. Effect of sleep on upper airway; Effects of upper airway …
Management of obstructive sleep apnoea/hypopnoea syndrome.
O Polo, M Berthon-Jones - The Lancet, 1994 - elibrary.ru
Considers several treatment methods for obstructive sleep apnea/hypopnea syndrome
(SAHS). Nasal continuous positive pressure (CPAP); Contraindications to CPAP; Surgery for …
(SAHS). Nasal continuous positive pressure (CPAP); Contraindications to CPAP; Surgery for …
Obstructive sleep apnoea and its cardiovascular consequences
TD Bradley, JS Floras - The Lancet, 2009 - thelancet.com
Obstructive sleep apnoea (OSA) is a common disorder in which repetitive apnoeas expose
the cardiovascular system to cycles of hypoxia, exaggerated negative intrathoracic pressure …
the cardiovascular system to cycles of hypoxia, exaggerated negative intrathoracic pressure …
Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome
HM Engleman, SE Martin, NJ Douglas, IJ Deary - The Lancet, 1994 - Elsevier
Continuous positive airway pressure (CPAP) is the treatment of choice for the sleep
apnoea/hypopnoea syndrome (SAHS); it is usually given with the aim of improving daytime …
apnoea/hypopnoea syndrome (SAHS); it is usually given with the aim of improving daytime …
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an …
JM Marin, SJ Carrizo, E Vicente, AGN Agusti - The Lancet, 2005 - thelancet.com
Background The effect of obstructive sleep apnoea-hypopnoea as a cardiovascular risk
factor and the potential protective effect of its treatment with continuous positive airway …
factor and the potential protective effect of its treatment with continuous positive airway …
On the cutting edge of obstructive sleep apnoea: where next?
Obstructive sleep apnoea is a common disease that is now more widely recognised
because of the rise in prevalence and the increasingly compelling data that shows major …
because of the rise in prevalence and the increasingly compelling data that shows major …
Sham continuous positive airway pressure for placebo-controlled studies in sleep apnoea
R Farré, L Hernández, JM Montserrat, M Rotger… - The Lancet, 1999 - thelancet.com
The sleep apnoea/hypopnoea syndrome is commonly treated with nasal continuous positive
airway pressure (CPAP). 1 The efficacy of CPAP has been assessed in comparison with …
airway pressure (CPAP). 1 The efficacy of CPAP has been assessed in comparison with …